InspireMD Historical Cash Flow
| NSPR Stock | USD 2.77 0.06 2.21% |
Analysis of InspireMD cash flow over time is an excellent tool to project InspireMD future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as End Period Cash Flow of 7.2 M or Total Cash From Financing Activities of 45.3 M as it is a great indicator of InspireMD ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining InspireMD latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether InspireMD is a good buy for the upcoming year.
InspireMD |
About InspireMD Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in InspireMD balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which InspireMD's non-liquid assets can be easily converted into cash.
InspireMD Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from InspireMD's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into InspireMD current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in InspireMD. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.At this time, InspireMD's Change To Netincome is relatively stable compared to the past year. As of 01/09/2025, Cash And Cash Equivalents Changes is likely to grow to about 8.6 M, though Change In Working Capital is likely to grow to (875.1 K).
InspireMD cash flow statement Correlations
Click cells to compare fundamentals
InspireMD Account Relationship Matchups
High Positive Relationship
High Negative Relationship
InspireMD cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 7.1M | (641K) | (7.4M) | 5.0M | 4.5M | 4.7M | |
| Free Cash Flow | (9.2M) | (13.6M) | (16.0M) | (16.8M) | (15.1M) | (14.3M) | |
| Change In Working Capital | 533K | (75K) | 395K | (801K) | (921.2K) | (875.1K) | |
| Begin Period Cash Flow | 5.5M | 12.6M | 12.0M | 4.6M | 5.3M | 7.0M | |
| Capital Expenditures | 88K | 344K | 473K | 381K | 438.2K | 460.1K | |
| Total Cash From Operating Activities | (9.1M) | (13.2M) | (15.5M) | (16.4M) | (14.7M) | (14.0M) | |
| Net Income | (10.5M) | (14.9M) | (18.5M) | (19.9M) | (17.9M) | (18.8M) | |
| End Period Cash Flow | 12.6M | 12.0M | 4.6M | 9.6M | 11.1M | 7.2M | |
| Total Cash From Financing Activities | 16.4M | 35.0M | (140K) | 37.5M | 43.2M | 45.3M | |
| Change To Inventory | (179K) | 272K | (478K) | (485K) | (436.5K) | (414.7K) | |
| Other Cashflows From Financing Activities | (187K) | (22.5M) | (140K) | (16.1M) | (14.5M) | (13.8M) | |
| Depreciation | 151K | 161K | 188K | 232K | 266.8K | 190.3K | |
| Other Non Cash Items | (4K) | (28K) | 14K | (381K) | (342.9K) | (325.8K) | |
| Change To Account Receivables | 347K | (748K) | 190K | (1.2M) | (1.1M) | (1.0M) | |
| Stock Based Compensation | 606K | 1.6M | 2.4M | 4.5M | 4.0M | 2.6M | |
| Total Cashflows From Investing Activities | (387K) | (187K) | (22.5M) | 8.4M | 7.6M | 8.0M | |
| Other Cashflows From Investing Activities | (121K) | (113K) | (86K) | (67.0K) | (60.3K) | (57.3K) | |
| Change To Liabilities | (283K) | (410K) | 657K | (234K) | (210.6K) | (200.1K) | |
| Change To Operating Activities | 64K | 719K | (242K) | 917K | 1.1M | 1.1M | |
| Investments | (187K) | (22M) | 8.4M | (16.1M) | (14.5M) | (13.8M) | |
| Issuance Of Capital Stock | 6.3M | 16.4M | 35.0M | 37.5M | 43.2M | 27.4M |
Pair Trading with InspireMD
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if InspireMD position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InspireMD will appreciate offsetting losses from the drop in the long position's value.Moving together with InspireMD Stock
Moving against InspireMD Stock
| 0.56 | DRIO | DarioHealth Corp | PairCorr |
| 0.55 | VERO | Venus Concept | PairCorr |
| 0.5 | VTAK | Catheter Precision | PairCorr |
| 0.34 | VNRX | Volitionrx | PairCorr |
| 0.32 | CI | Cigna Corp Sell-off Trend | PairCorr |
The ability to find closely correlated positions to InspireMD could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace InspireMD when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back InspireMD - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling InspireMD to buy it.
The correlation of InspireMD is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as InspireMD moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if InspireMD moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for InspireMD can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for InspireMD Stock Analysis
When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.